Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers
- 31 August 1999
- journal article
- review article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 61 (2), 65-82
- https://doi.org/10.1054/plef.1999.0038
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Prolonged hepatic warm ischemia in non-heart-beating donors: Protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantationSurgery, 1998
- Loss of Activity of Plasma Platelet-Activating Factor Acetylhydrolase Due to a Novel Gln281→Arg MutationBiochemical and Biophysical Research Communications, 1997
- THE PAF ANTAGONIST TCV-309 REDUCES GRAFT PMN INFILTRATION AND ENHANCES EARLY FUNCTION OF 24-HOUR-PRESERVED RAT KIDNEYS WITH LONG WARM ISCHEMIATransplantation, 1996
- PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human PlasmaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?Kidney International, 1994
- Blood rheology in patients with transient ischemic attacks.Stroke, 1988
- Effects of 1Oalkyl2acetylglycero3phosphocholine (platelet activating factor) on cardiac function in perfused guinea-pig heartLife Sciences, 1985
- Effect of 1-alkyl-2-acetyl--glycero-3-phosphorylcholine inhibitor on the reduction of one-kidney, one clip hypertension after unclipping in the ratLife Sciences, 1984
- Potent hypotensive activity of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine in spontaneously hypertensive ratBiochemical and Biophysical Research Communications, 1982
- Antihypertensive activity of an alkyl ether analog of phosphatidylcholineBiochemical and Biophysical Research Communications, 1979